EMEA-002196-PIP01-17

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Human Neutrophil Elastase Inhibitor (CHF6333)

Decision numberP/0367/2017
PIP numberEMEA-002196-PIP01-17
Pharmaceutical form(s)Pressurised inhalation, suspension
Condition(s)/indication(s)

Treatment of bronchiectasis

Route(s) of administrationInhalation use
PIP applicant

Chiesi Farmaceutici S.p.A
Tel. +39 05212791
E-mail: info@chiesi.com

Decision typeRW: decision refers to a refusal on a request for request on a waiver in all age groups for all conditions, indications

Decision